- Home
- APLT vs XMTR Comparison
APLT vs XMTR Comparison
Compare APLT & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- XMTR
- Stock Information
- Founded
- APLT 2016
- XMTR 2013
- Country
- APLT United States
- XMTR United States
- Employees
- APLT N/A
- XMTR N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- XMTR Industrial Machinery/Components
- Sector
- APLT Health Care
- XMTR Technology
- Exchange
- APLT Nasdaq
- XMTR Nasdaq
- Market Cap
- APLT 44.0M
- XMTR 1.6B
- IPO Year
- APLT 2019
- XMTR 2021
- Fundamental
- Price
- APLT $0.40
- XMTR $33.62
- Analyst Decision
- APLT Buy
- XMTR Buy
- Analyst Count
- APLT 7
- XMTR 11
- Target Price
- APLT $6.10
- XMTR $34.82
- AVG Volume (30 Days)
- APLT 2.6M
- XMTR 591.6K
- Earning Date
- APLT 08-06-2025
- XMTR 08-07-2025
- Dividend Yield
- APLT N/A
- XMTR N/A
- EPS Growth
- APLT N/A
- XMTR N/A
- EPS
- APLT N/A
- XMTR N/A
- Revenue
- APLT $265,000.00
- XMTR $573,810,000.00
- Revenue This Year
- APLT $1,768.13
- XMTR $21.52
- Revenue Next Year
- APLT $292.85
- XMTR $17.20
- P/E Ratio
- APLT N/A
- XMTR N/A
- Revenue Growth
- APLT N/A
- XMTR 19.35
- 52 Week Low
- APLT $0.30
- XMTR $11.33
- 52 Week High
- APLT $10.62
- XMTR $45.33
- Technical
- Relative Strength Index (RSI)
- APLT 58.87
- XMTR 57.44
- Support Level
- APLT $0.32
- XMTR $31.87
- Resistance Level
- APLT $0.36
- XMTR $36.76
- Average True Range (ATR)
- APLT 0.04
- XMTR 1.47
- MACD
- APLT 0.01
- XMTR 0.15
- Stochastic Oscillator
- APLT 94.92
- XMTR 68.92
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.